Press release
Non-melanoma Skin Cancer Market is Expected to Progress at a CAGR of 5.7% to Reach US$ 8,859.6 Million by 2034
The non-melanoma skin cancer market is projected to be valued at US$ 5,068.7 million in 2024 and is anticipated to grow at a CAGR of 5.7% through 2034, reaching US$ 8,859.6 million by the end of the forecast period.The growing incidence of skin cancer is driving the demand for effective treatment solutions. One of the key contributing factors is the rise in global temperatures due to climate change, which increases UV exposure and elevates the risk of developing skin cancer. As non-melanoma skin cancer continues to affect a larger segment of the population, the market is experiencing steady growth to meet the increasing demand for diagnosis and treatment options.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9737
Which Factors Are Driving the Non-Melanoma Skin Cancer Market?
"Advancements in Radiation Therapy Equipment Enhance Patient Comfort and Accessibility"
Radiation therapy remains a widely used and effective treatment for non-melanoma skin cancer. As the number of patients opting for this method continues to rise, manufacturers are prioritizing the development of more patient-friendly equipment. The introduction of portable and compact radiation therapy machines is a key advancement, allowing greater flexibility and ease during treatment. These innovations reduce the need for patients to remain confined to a single treatment area, improving their overall experience and contributing to the growing adoption of radiation therapy in non-melanoma skin cancer care.
Country-wise Insights
North America Continues to Lead, While East Asia Emerges as a Fast-Growing Market
North America holds a dominant position in the non-melanoma skin cancer market, with an estimated market value of US$ 2,941.0 million in 2024, accounting for a substantial 58.0% share. Although its market share is expected to decline slightly over the forecast period, the region remains highly lucrative. By 2034, North America is projected to reach a market value of US$ 3,930.0 million, registering a CAGR of 2.9%, and accounting for 44.4% of the global market.
In contrast, East Asia is set to grow at a comparatively faster rate. With a modest market share of 0.8% and a value of US$ 40.0 million in 2024, the region is expected to expand at a CAGR of 5.6% through 2034. By the end of the forecast period, East Asia's market value is anticipated to reach US$ 78.0 million, reflecting an increase in its share to 0.9%. This growth underscores the region's emerging potential driven by rising awareness, improved healthcare infrastructure, and growing demand for cancer treatment solutions.
Category-wise Insights
Radiation Therapy and Basal Cell Carcinoma Dominate the Market Landscape
Radiation therapy stands out as the leading treatment modality in the non-melanoma skin cancer market, projected to hold a significant 88.6% share in 2024. Its widespread use is attributed to its effectiveness and adaptability in treating various stages of skin cancer. Photodynamic therapy follows as the second most utilized treatment, expected to capture an 8.6% market share in the same year, reflecting its growing adoption as a less invasive alternative.
From an indication perspective, basal cell carcinoma remains the most prevalent form of non-melanoma skin cancer, accounting for an estimated 75.7% of the market in 2024. Squamous cell carcinoma, while less common, still represents a substantial portion, with a projected market share of 24.3%. This segmentation highlights the dominance of basal cell carcinoma in clinical incidence and treatment demand.
Competitive Landscape
To enhance the effectiveness of treatment options, companies operating in the non-melanoma skin cancer market are making significant investments in research and development. Strategic collaborations with academic institutions and research organizations are also on the rise, with companies providing financial support to accelerate scientific advancements.
In addition to product innovation, market players are leveraging public health campaigns to boost awareness around non-melanoma skin cancer. These initiatives aim to increase early detection rates and encourage more individuals to seek timely treatment, ultimately driving market growth.
Key players in the market include Amgen Inc., Regeneron Pharmaceuticals Inc., Almirall, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis AG, Eli Lilly and Company, and Sun Pharmaceutical Industries Ltd.
Recent Developments:
November 2023: DermaSensor announced encouraging results for its AI-powered elastic scattering spectroscopy (ESS) device, demonstrating strong performance in detecting skin cancers.
August 2023: SkinCure Oncology expanded its services to Kentucky, USA, offering Image-Guided Superficial Radiation Therapy (Image-Guided SRT), a non-invasive alternative to surgery for treating skin cancers.
June 2023: Sirnaomics Ltd. revealed that its siRNA-based treatment for squamous cell carcinoma had progressed to Phase 3 clinical trials, following favorable outcomes from Phase 2.
Browse Full Report: https://www.factmr.com/report/non-melanoma-skin-cancer-market
Segmentation of Non-melanoma Skin Cancer Market Research
By Treatment Type:
Radiation Therapy
Chemotherapy
Photodynamic Therapy
By Indication:
Basal Cell Carcinoma
Squamous Cell Carcinoma
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Region:
North America
Europe
Latin America
East Asia
South Asia & Oceania
Middle East & Africa
Check out More Related Studies Published by Fact.MR:
Medical Device Coating Market
https://www.factmr.com/report/5421/coatings-for-medical-devices-market
Medical Dynamometer Market
https://www.factmr.com/report/4811/medical-dynamometer-market
Disposable Endoscopes Market
https://www.factmr.com/report/disposable-endoscopes-market
Dermatology CRO Market
https://www.factmr.com/report/dermatology-cro-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-melanoma Skin Cancer Market is Expected to Progress at a CAGR of 5.7% to Reach US$ 8,859.6 Million by 2034 here
News-ID: 4054400 • Views: …
More Releases from Fact.MR

Latin America's Refuse-Derived Fuel (RDF) Market is Estimated to Reach $110.19 M …
It is estimated that Latin America's refuse-derived fuel (RDF) sales will reach US$ 110.19 million by the end of 2034, growing at a compound annual growth rate (CAGR) of 3.1% from US$ 81.2 million in 2024.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9782
RDF is made by processing several kinds of solid waste, especially non-recyclable materials and the organic parts of municipal solid waste (MSW). …

Pure Monomer Resin Market is Forecasted to Reach US$ 1.29 Billion by 2034 | Fact …
By the end of 2034, the pure monomer resin market is expected to have grown from a 2024 valuation of US$ 722.3 million to US$ 1.29 billion, with a compound annual growth rate (CAGR) of 6%.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=5735
Chemical compounds with the ability to polymerize, pure monomer resins are used in many different sectors, particularly in polymerization procedures. Because they…

Ductile Iron Pipe Market is Expected to Reach at US$ 15.34 billion by 2034 | Fac …
The market for ductile iron pipes is expected to grow steadily at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2034, from an estimated $9.33 billion in 2024 to $15.34 billion by the end of 2034.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4182
Ductile iron pipes represent a vital component of water and wastewater infrastructure globally, providing robust solutions for the efficient transportation…

Liquid Masterbatch Market is Predicted to Grow at US$ 19.2 billion by 2034 | Fac …
The global Liquid Masterbatch Market estimated to be valued at US$ 11.78 billion in 2024, is projected to expand at a CAGR of 5% from 2024 to 2034.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9781
Liquid masterbatches are a type of plastic compound that is dissolved in a solvent and then extruded through a small opening, similar to a spinneret. The liquid is propelled through the…
More Releases for Skin
Bellueur Skin Canada Review: Does Bellueur Skin Really Work?
Bellueur Skin Canada Only: https://rebrand.ly/01b756
Best Anti Aging Cream US Only: https://rebrand.ly/eee7f0
Are you feeling disappointed with your facial skin? Oh, not only you, many of us nowadays feel the same. Everybody wants healthy and bright skin. No one likes dull, wrinkled, and tainted skin. As we grow older our skin starts to lose firmness and gets wrinkled and dull. The Epidermis, the outermost layer of our skin keeps the moisture in…
Juventus Skin Cream-Does Juventus Skin Cream Work-Complete Info
You Might Have asked why a Few Folks Juventus Skin Possess such Flawless and Flawless pores and skin. What exactly do they actually do and what things do they utilize to earn their skin glow shiny? During our teenagers, have to have skin that is exceptional. Whatever the instance, together with all of the age this is growing, it begins to decompose in a extraordinary way. Both tremendous desires are…
Global Anti-Aging Facial Mask Sales Market For End Users/Applications - Oil Skin …
Researchmoz added Most up-to-date research on "Global Anti-Aging Facial Mask Sales Market For End Users/Applications - Oil Skin, Normal Skin, Dry Skin and Combination Skin" to its huge collection of research reports.
In this report, the global Anti-Aging Facial Mask market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and…
Australia Tissue Engineered - Skin Substitutes Market 2024: Biologic Skin Substi …
"The Latest Research Report Australia Tissue Engineered - Skin Substitutes Market Outlook to 2024 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Skin Substitutes Market
GlobalDatas new report, Australia Tissue Engineered - Skin Substitutes Market Outlook to 2024, provides key market data on the Australia Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in…
Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights, 2017
Orbis Research delivers key insights on the global Complicated Skin And Skin Structure Infections (cSSSI) market in a new report titled “Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights, 2017” In this report, Orbis Research sheds light on the various factors and trends impacting market growth over the forecast period (2017 – 2022).
“Complicated Skin And Skin Structure Infections (cSSSI)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs…
Latest Report: Global Skin And Skin Structure Infections (SSSI) Market
Marketresearchreports.biz has added a new research report on the "Skin And Skin Structure Infections (SSSI)-API Insights, 2017" to its collection.
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API…